SciELO - Scientific Electronic Library Online

 
vol.19 issue12Role of Clostridium difficile infection in the relapse of ulcerative colitisDiagnostic-therapeutic management of parathyroid carcinoma author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Anales de Medicina Interna

Print version ISSN 0212-7199

Abstract

IZQUIERDO ALONSO, J. L.. Clinical benefits of tiotropium, a new anticholinergic bronchodilatador . An. Med. Interna (Madrid) [online]. 2002, vol.19, n.12, pp.44-47. ISSN 0212-7199.

Bronchodilators are, at the present time, the mainstay of symptomatic therapy in patients with chronic obstructive pulmonary disease (COPD). Anticholinergics are the first steep in the clinical management of these patients although its short half life constitutes a serious limitation in patients with persistent symptoms. However, there have been some important developments on this area. Tiotropium bromide, used once daily shows several clinical advantages when it is compared with ipratropium bromide or with long acting beta-2 agonists. This suggests than tiotropium bromide could be in coming years one of the first options for the treatment of COPD.

Keywords : COPD; Anticholinergics; Tiotropium.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License